1. Home
  2. GFAI vs CURX Comparison

GFAI vs CURX Comparison

Compare GFAI & CURX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Guardforce AI Co. Limited

GFAI

Guardforce AI Co. Limited

HOLD

Current Price

$0.55

Market Cap

13.1M

ML Signal

HOLD

CURX

Curanex Pharmaceuticals Inc

BUY

Current Price

$0.37

Market Cap

12.4M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
GFAI
CURX
Founded
2018
2018
Country
Singapore
United States
Employees
1698
6
Industry
Diversified Commercial Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.1M
12.4M
IPO Year
N/A
2025

Fundamental Metrics

Financial Performance
Metric
GFAI
CURX
Price
$0.55
$0.37
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$4.50
N/A
AVG Volume (30 Days)
304.1K
98.0K
Earning Date
04-21-2026
09-09-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$14.12
N/A
Revenue Next Year
$10.25
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.38
$0.26
52 Week High
$1.50
$9.18

Technical Indicators

Market Signals
Indicator
GFAI
CURX
Relative Strength Index (RSI) 54.72 35.27
Support Level $0.52 $0.32
Resistance Level $0.60 $0.42
Average True Range (ATR) 0.05 0.04
MACD 0.01 -0.01
Stochastic Oscillator 59.25 10.35

Price Performance

Historical Comparison
GFAI
CURX

About GFAI Guardforce AI Co. Limited

Guardforce AI Co Ltd is an integrated solution provider, specializing in security solutions, and also focuses on implementing AI and robotics solutions to improve business operational efficiency and sales and marketing processes, especially for the retail and travel industry in the Asia Pacific. The company's operating business segments include Secured Logistics, AI & Robotics Solution Business, General Security Solutions, and Corporate and others. A majority of its revenue is generated from the Secured Logistics segment, which includes services like cash-in-transit, dedicated vehicles to banks, ATM management, cash center operations, cash processing, coin processing, cheque center, and cash deposit machine solutions.

About CURX Curanex Pharmaceuticals Inc

Curanex Pharmaceuticals Inc is engaged in discovering, developing, and commercializing botanical drugs for treating unmet medical needs in patients with inflammatory disease. Its compound, Phyto-N, is in preclinical research for six indications: ulcerative colitis, atopic dermatitis, COVID-19, type 2 diabetes, nonalcoholic fatty liver disease (NAFLD) and gout. Phyto-N, is a proprietary botanical extract with chemical components and pharmacological activities that harnesses potential anti-inflammatory properties of a medicinal plant.

Share on Social Networks: